Dr. Hönle Balance Sheet Health
Financial Health criteria checks 3/6
Dr. Hönle has a total shareholder equity of €93.6M and total debt of €52.7M, which brings its debt-to-equity ratio to 56.3%. Its total assets and total liabilities are €168.9M and €75.3M respectively. Dr. Hönle's EBIT is €12.6M making its interest coverage ratio 6.3. It has cash and short-term investments of €6.7M.
Key information
56.3%
Debt to equity ratio
€52.68m
Debt
| Interest coverage ratio | 6.3x |
| Cash | €6.70m |
| Equity | €93.58m |
| Total liabilities | €75.32m |
| Total assets | €168.90m |
Recent financial health updates
We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt
Oct 11
Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 03Dr. Hönle (ETR:HNL) Has No Shortage Of Debt
Sep 29Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 14We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt
Mar 03These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively
Nov 22
Recent updates
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%
Sep 26Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S
Aug 06Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?
Jul 02Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear
Feb 08We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt
Oct 11Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?
Aug 07Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 03The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence
Nov 03Dr. Hönle (ETR:HNL) Has No Shortage Of Debt
Sep 29There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital
Jul 06Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal
Feb 20Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 15Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 14Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?
May 30Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital
May 17Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)
Mar 29Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?
Mar 16We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt
Mar 03Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?
Feb 20We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide
Feb 08Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?
Jan 25Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?
Jan 11What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?
Dec 27Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 15Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?
Dec 03These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively
Nov 22Financial Position Analysis
Short Term Liabilities: HNL's short term assets (€61.5M) exceed its short term liabilities (€31.0M).
Long Term Liabilities: HNL's short term assets (€61.5M) exceed its long term liabilities (€44.3M).
Debt to Equity History and Analysis
Debt Level: HNL's net debt to equity ratio (49.1%) is considered high.
Reducing Debt: HNL's debt to equity ratio has increased from 13.7% to 56.3% over the past 5 years.
Debt Coverage: HNL's debt is not well covered by operating cash flow (9.2%).
Interest Coverage: HNL's interest payments on its debt are well covered by EBIT (6.3x coverage).